These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 2144361

  • 41. [Hormonal receptors and breast cancer. Results on 589 patients].
    Bonneterre J, Peyrat JP, Vandewalle B, Vennin P, Beuscart R, Lefebvre J, Demaille A.
    LARC Med; 1984 Oct; 4(8):467-72. PubMed ID: 6096652
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Stimulation of DNA synthesis by prolactin in human breast tumor explants. Relation to prolactin receptors.
    Peyrat JP, Djiane J, Bonneterre J, Vandewalle B, Vennin P, Delobelle A, Depadt G, Lefebvre J.
    Anticancer Res; 1984 Oct; 4(4-5):257-61. PubMed ID: 6091527
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Serum prolactin, androgens, oestradiol and progesterone in adolescent girls with or without a family history of breast cancer.
    Boffard K, Clark GM, Irvine JB, Knyba RE, Bulbrook RD, Wang DY, Kwa HG.
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1071-7. PubMed ID: 6461557
    [No Abstract] [Full Text] [Related]

  • 47. Prolactin: the forgotten hormone of human breast cancer.
    Vonderhaar BK.
    Pharmacol Ther; 1998 Aug; 79(2):169-78. PubMed ID: 9749881
    [Abstract] [Full Text] [Related]

  • 48. Prolactin binding by human mammary carcinoma: relationship to estrogen receptor protein concentration and patient age.
    Rae-Venter B, Nemoto T, Schneider SL, Dao TL.
    Breast Cancer Res Treat; 1981 Aug; 1(3):233-43. PubMed ID: 6293628
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: a preliminary report.
    Bhatavdekar J, Patel D, Ghosh N, Vora H, Shah N, Karelia N, Balar D, Chikhlikar P, Dave R.
    J Surg Oncol; 1994 Apr; 55(4):246-9. PubMed ID: 8159006
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Biological actions of prolactin in human breast cancer.
    Shiu RP, Murphy LC, Tsuyuki D, Myal Y, Lee-Wing M, Iwasiow B.
    Recent Prog Horm Res; 1987 Apr; 43():277-303. PubMed ID: 3306837
    [No Abstract] [Full Text] [Related]

  • 55. [Epidermal growth factor receptors and their ligands as molecular markers of breast cancer prognosis and hormone sensitivity].
    Gershteĭn ES, Kushlinskiĭ NE, Dvorova EK, Kostyleva OI, Muaviia MA, Letiagin VP.
    Klin Lab Diagn; 1998 Feb; (2):9-13. PubMed ID: 9553337
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Prolactin in pathology of the breast. Clinical study ].
    Latteri M, Bajardi G, Castiglione C, Caronia F, Maragliano S, Briganti A, Latteri S, Bellanca L.
    Minerva Med; 1980 Jul; 71(27):1915-20. PubMed ID: 7393472
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.